Navigation Links
Innophos Holdings, Inc. Reports First Quarter 2013 Results
Date:4/29/2013

he year ago period. 

Recent Trends and OutlookMarket demand was flat for the first quarter 2013, with a strong start to the quarter offset by a weak finish that particularly affected higher margin market segments. We continue to expect only modest market growth in 2013.

Momentum behind our growth strategy continues to improve, as evidenced by record export sales from the U.S. for the first quarter 2013, particularly to Asia Pacific and Europe.  Our recently granted food manufacturing license in Taicang, China allows us to begin operations there and build on a strong start to the year in that zone. 

We continue to expect growth in Specialty Phosphates for the second half of 2013 excluding the benefit of recent acquisitions, to be within our 4-6% long-term target range. For the second quarter, the improvement seen towards the end of the first quarter in Mexico manufacturing performance gives us confidence the impact of production restrictions will be significantly reduced. However, there may be some residual effect in the second quarter as we continue to implement our long-term equipment upgrade program, so while we anticipate good sequential sales improvement, second quarter volumes for Mexico Specialty Phosphates are likely to be moderately lower than the year ago level with a price variance similar to that seen in the first quarter. We are targeting continued improvement in U.S. and Canada volumes and expect this to offset the Mexico volume decline in comparison to the second quarter last year.

Strong performance by our recent acquisitions is expected to continue, and this, together with the full year benefit of the two acquisitions made in 2012, is expected to contribute an additional 5% revenue growth for the full year 2013 in comparison to 2012.

We do not expect any major change in raw material purchase prices or underlying selling prices through the second quarter 2013.

Specialty Phosphates ope
'/>"/>

SOURCE Innophos Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Innophos CFO To Present At 2013 Sidoti Emerging Growth Conference
2. Innophos Holdings, Inc. Announces Annual Meeting
3. Innophos Holdings, Inc. Reports Fourth Quarter And Full Year 2012 Results
4. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter And Full Year 2012 Results
5. Innophos To Present At 2012 KeyBanc Capital Markets Basic Materials & Packaging Conference
6. Zimmer Holdings, Inc. Reports First Quarter 2013 Financial Results
7. Hill-Rom Holdings, Inc. to Host Investor Conference May 7
8. Hill-Rom Holdings, Inc. Hosts Fiscal 2013 Second Quarter Earnings Conference Call and Webcast
9. Organovo Holdings, Inc. Announces Change of Fiscal Year
10. PDP Holdings, LLC Announces Support for Health and Human Services Office of Inspector General Guidance
11. Mr. William Lerner, Esq. nominated to the Board of Directors of Sanomedics International Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), ... Technology (Tray-style, Manifold, & Rotary) & Geography - ... MarketsandMarkets, defines and segments the lyophilization market on ... with analyses and projections of the market size ...
(Date:9/19/2014)... Fla. , Sept. 19, 2014  The body ... with the publication of two papers this past week.  ... – Head and Neck Surgery , finds that ... and subjective measures of sleep disordered breathing, leading the ... reduction in obstructive sleep apnea severity and improvement of ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. , Sept. 19, ... (PGDx), a provider of advanced cancer genome analysis ... a leader in discovering and developing highly selective ... the first-ever comprehensive genomic study of malignant mixed ... of the female reproductive system, also known as ...
Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Medical, Inc., the wholly-owned operating subsidiary of Patient ... the recently released 2011-2012 U.S. News and World ... of the SurgiCount Safety-Sponge® System, a clinically proven ... common surgical errors, retained surgical sponges.  Only 17 ...
... A new policy recommendation released on 20 July by ... of serological (blood) tests to diagnose active tuberculosis (TB). ... are different to QuantiFERON, which measures responses of white ... Active tuberculosis occurs when the TB organism has overcome ...
Cached Medicine Technology:SurgiCount Medical Announces Expanded Honor Roll Hospital Users, Landmark Product Usage Milestones Achieved 2SurgiCount Medical Announces Expanded Honor Roll Hospital Users, Landmark Product Usage Milestones Achieved 3Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis 2Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis 3Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis 4
(Date:9/20/2014)... 20, 2014 “Motherhood is a wonderful gift ... in their latest article , “We know that you ... can—and that’s what we want to do as well.” , ... and should expect from their Family Physicians who practice obstetrics ... new motherhood. , To learn more about Community Health ...
(Date:9/19/2014)... “Copay coupons,” a drug manufacturer marketing tactic often ... with prescription drug coverage, may now be infiltrating Medicare ... from the Department of Health and Human Services Office ... suppliers from offering side-payments to increase sales of goods ... report highlights that two recent surveys, including one by ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... PR News at the Platinum PR and Top Places ... Hyatt in New York City. Camino received honorable mentions ... Shoestring Campaign” — for its work elevating Latina voices ... this incredible organization and be a part of its ...
(Date:9/19/2014)... 19, 2014 According to a report ... embattled blood-thinner Xarelto, named as defendants in several lawsuits ... have moved the court to dismiss those suits because ... sufficient connection with Philadelphia.* The cases include, for instance, ... 140304328; Pa. Comm. Pls., Philadelphia Cty.), which was brought ...
(Date:9/19/2014)... (HealthDay News) -- Although there is mounting evidence ... middle-aged and older adults in the United States ... to new research. Less than one-quarter of ... by the Department of Health and Human Services, ... for promoting health and fitness and staying independent, ...
Breaking Medicine News(10 mins):Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News:Camino Public Relations Honored for Raising Latina Voices in National Health Care, Immigration Debates 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Adults Over 45 Not Meeting U.S. Muscle Strengthening Guidelines, Study Says 2
... July 24 /PRNewswire-Asia/ -- Neusoft Medical Systems Co.,Ltd. (Neusoft ... announced that its newly developed Computed,Tomography(CT) system, NeuViz 16 ... and is also marked as the first of its ... was shipped to its U.S.-based customers,recently, Neusoft Medical has ...
... offer a medical heads-up, study says, , FRIDAY, July ... trauma patients could help medical personnel identify those at ... study says. , People who abuse alcohol often ... about potentially serious health needs. But even if people ...
... , , , ... ) will provide free access for the uninsured and underinsured to ... p.m. Saturday and Sunday, July 25 and 26, at the W.O. Walker ... sponsored by MedWorks and will provide 1100 medical, 300 vision and 200 ...
... 24 Dialysis Corporation of America (Nasdaq: DCAI ) ... results on Wednesday August 5, 2009, after the close of the ... with its second quarter 2009 earnings release the following morning, Thursday, ... , Those interested in participating in the August ...
... ANN ARBOR, Mich., July 24 As the economy continues ... choices about how to spend what money they have, and children -- ... bracket -- are more at risk because of it. , ... Children,s Health taken in May 2009 shows 44 percent of families, financial ...
... , , , ... DVA ), a leading provider of kidney care services for those ... dialysis facilities in Colorado have received the 2009 End Stage Renal ... granted by the Intermountain ESRD Network (Network 15), a federally mandated, ...
Cached Medicine News:Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 2Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 3Health News:Alcohol and Trauma: Blood Test Gets to the Truth 2Health News:U.S. Senator Sherrod Brown to Lend Support at MedWorks' Free Medical Clinic This Weekend 2Health News:Dialysis Corporation of America Announces Second Quarter 2009 Earnings Release Date 2Health News:Recession Stressful for Many Kids, Toughest on Poor and Uninsured 2Health News:Recession Stressful for Many Kids, Toughest on Poor and Uninsured 3Health News:Six DaVita Clinics in Colorado Receive Silver Award for Clinical Excellence 2Health News:Six DaVita Clinics in Colorado Receive Silver Award for Clinical Excellence 3
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... Coagulation tubes contain a buffered ... available with a citrate concentration ... 0.129 mol/l (3.8%). The mixing ... solution to 9 parts blood. ...
... are available in two versions. ... a clotting activator and is ... serum is required for testing ... is suitable where the testing ...
Medicine Products: